The business generates roughly $2.0M–$2.3M in annual revenue with 70%+ gross margins and adjusted EBITDA typically in the mid–$200k to low–$400k range, supported by about 3,700 yearly appointments and over 10,000 active patient files. It serves a primarily female patient base aged 30–60 in an affluent, growing metro, operating on a cash-pay basis with no insurance reimbursement, and benefits from strong repeat visit behavior and word-of-mouth referrals.

The company delivers a broad mix of surgical procedures for face, breast, and body alongside non-surgical offerings such as injectables, skin resurfacing, and body contouring. Surgical work represents just over half of revenue, with operating-room and surgical fees, materials, non-surgical services, and retail products contributing diversified income streams. A certified Class C operating room, board-certified lead physician, and participation in leading professional societies reinforce a high standard of care, regulatory compliance, and brand trust in the commercial healthcare aesthetics segment.

The business earns money through high-margin, self-pay procedures and recurring medspa-style services, supported by a seasoned clinical and administrative team and a modern, single-level facility of about 4,600 sq. ft. within a multi-unit building that is also available for acquisition. One neighboring unit is leased to a tenant and another remains unbuilt, providing clear runway to expand operating-room capacity or add additional treatment rooms. With the owner planning for retirement and open to a multi-year transition, a buyer gains continuity of clinical expertise plus a structured path to introduce an associate physician, expand minimally invasive offerings, and add complementary wellness and longevity programs while leveraging the existing brand, certifications, and loyal patient base for scale.